Pain is an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage. Due to pain being a complex, subjective phenomenon, defining pain has been a challenge. In medical diagnosis, pain is regarded as a symptom of an underlying condition.
Rilento is focused on developing acute pain management solutions that do not rely on addictive opioids, offering competitive performance without dangerous side-effects, improving pain management outcomes and quality of life for clinicians and patients who seek alternatives to opioids.
Rilento uses the biology of the healing process to inform the design and performance of tailored time release compositions that address the multi-factor contributions to acute pain.
Rilento has developed a unique and efficient approach for rapid concept prototyping and testing to maximize fit-for-purpose formulations with broad clinician appeal:
Copyright © 2017-2018 Rilento Pharma, LLC